Evidence map›Paper›PMID 38174960›Full record

ArticleJournal of the American Chemical Society2024

A Fluorinated BODIPY-Based Zirconium Metal-Organic Framework for

Xu Chen, Bárbara B Mendes, Yunhui Zhuang, João Conniot, Sergio Mercado Argandona, Francesca Melle, Diana P Sousa, David Perl, Alexandru Chivu, Hirak K Patra and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. DNA-mimic for Specific Surface Functionalization of Zr-MOFs for Bacterial Targeting.Angewandte Chemie (International ed. in English) · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Electrochemiluminescence Drives Photodynamic Therapy In Vivo.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Metal-Ligand Complexes as Multifunctional Platforms for Photo-Activated Cancer Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Xu ChenThe Adsorption & Advanced Materials Laboratory (A2ML), Department of Chemical Engineering & Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.ORCID 0000-0001-7793-036X
Bárbara B MendesToxOmics, NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade Nova de Lisboa, Lisboa 2775-405, Portugal.ORCID 0000-0001-8630-1119
Yunhui ZhuangThe Adsorption & Advanced Materials Laboratory (A2ML), Department of Chemical Engineering & Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.ORCID 0000-0001-8941-3749
João ConniotToxOmics, NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade Nova de Lisboa, Lisboa 2775-405, Portugal.
Sergio Mercado ArgandonaThe Adsorption & Advanced Materials Laboratory (A2ML), Department of Chemical Engineering & Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.ORCID 0000-0002-4246-3842
Francesca MelleThe Adsorption & Advanced Materials Laboratory (A2ML), Department of Chemical Engineering & Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.
Diana P SousaToxOmics, NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade Nova de Lisboa, Lisboa 2775-405, Portugal.ORCID 0000-0003-3474-5417
David PerlSynchrotron SOLEIL-UR1, L'Orme des Merisiers, Départementale 128, 91190 Saint-Aubin, France.ORCID 0000-0003-2757-0292
Alexandru ChivuDepartment of Surgical Biotechnology, University College London, London NW3 2PF, U.K.ORCID 0000-0002-8573-9159
Hirak K PatraDepartment of Surgical Biotechnology, University College London, London NW3 2PF, U.K.ORCID 0000-0002-6142-5489
William ShepardSynchrotron SOLEIL-UR1, L'Orme des Merisiers, Départementale 128, 91190 Saint-Aubin, France.ORCID 0000-0002-5724-1193
João CondeToxOmics, NOVA Medical School, Faculdade de Ciências Médicas, NMS|FCM, Universidade Nova de Lisboa, Lisboa 2775-405, Portugal.ORCID 0000-0001-8422-6792
David Fairen-JimenezThe Adsorption & Advanced Materials Laboratory (A2ML), Department of Chemical Engineering & Biotechnology, University of Cambridge, Philippa Fawcett Drive, Cambridge CB3 0AS, U.K.ORCID 0000-0002-5013-1194
Agricultural Development Advisory Service (United Kingdom) · GBUniversidade Nova de Lisboa · PTSynchrotron soleil · FRUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photodynamic therapy (PDT), an emergent noninvasive cancer treatment, is largely dependent on the presence of efficient photosensitizers (PSs) and a sufficient oxygen supply. However, the therapeutic efficacy of PSs is greatly compromised by poor solubility, aggregation tendency, and oxygen depletion within solid tumors during PDT in hypoxic microenvironments. Despite the potential of PS-based metal-organic frameworks (MOFs), addressing hypoxia remains challenging. Boron dipyrromethene (BODIPY) chromophores, with excellent photostability, have exhibited great potential in PDT and bioimaging. However, their practical application suffers from limited chemical stability under harsh MOF synthesis conditions. Herein, we report the synthesis of the first example of a Zr-based MOF, namely, 69-L

Indexed as

Boron CompoundsMetal-Organic FrameworksNeoplasmsPhotochemotherapyTriple Negative Breast NeoplasmsAnimalsCell Line, TumorHumansHypoxiaMiceOxygenPhotosensitizing AgentsTumor MicroenvironmentZirconium4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneBoron CompoundsMetal-Organic FrameworksOxygenPhotosensitizing AgentsZirconium

Identifiers

PMID38174960
PMCPMC10797627
OpenAlexW4390580070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.